Company intelligence / Profile preview

Spino Modulation

Montreal, Quebec, Canadaspinologics.ca ↗

Ownership: Private
Development stage: Preclinical

Overview

Spino Modulation is developing the MIScoli System, an investigational vertebral body tethering device for treating adolescent idiopathic scoliosis. The system aims to reduce spinal deformity and prevent progression while preserving motion. It has received FDA Breakthrough Device Designation and is currently being evaluated in a pivotal clinical trial in Canada. The MIScoli System offers a less invasive alternative to traditional spinal fusion surgery for young adolescents at high risk of curve progression[1][3][5][6].

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Spino Modulation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spino Modulation.

Explore the full profile